SARS Virus (classification) < SARS Virus (drug effects) < SARS Virus (enzymology)

Facettes : AffPays.f Mesh.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 274.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000037 (2003)	Martin Enserink ; Gretchen Vogel	Infectious diseases. Deferring competition, global net closes in on SARS.
000063 (2003)	Dennis Normile	Infectious diseases. Battling SARS on the frontlines.
000081 (2003)	Kanchan Anand [Allemagne] ; John Ziebuhr ; Parvesh Wadhwani ; Jeroen R. Mesters ; Rolf Hilgenfeld	Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs.
000193 (2003)	Jesús Fco Bermejo Martin [Espagne] ; José L. Jimenez ; Angeles Mu Oz-Fernández	Pentoxifylline and severe acute respiratory syndrome (SARS): a drug to be considered.
000204 (2003)	Quan-Ying He [République populaire de Chine]	[Recommendations on corticosteroid therapy in patients with severe acute respiratory syndrome].
000262 (2003)	Kuo-Chen Chou [États-Unis] ; Dong-Qing Wei ; Wei-Zhu Zhong	Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS.
000305 (2003)	Renli Zhang [République populaire de Chine] ; Zhongmin Guo ; Jiahai Lu ; Jinxiu Meng ; Canquan Zhou ; Ximei Zhan ; Bing Huang ; Xinbing Yu ; Min Huang ; Xinghua Pan ; Wenhua Ling ; Xigu Chen ; Zhuoyue Wan ; Huanying Zheng ; Xinge Yan ; Yifei Wang ; Yanchao Ran ; Xinjian Liu ; Junxin Ma ; Chengyu Wang ; Biliang Zhang	Inhibiting severe acute respiratory syndrome-associated coronavirus by small interfering RNA.
000344 (2003)	Yossef Kliger [Israël] ; Erez Y. Levanon	Cloaked similarity between HIV-1 and SARS-CoV suggests an anti-SARS strategy.
000349 (2003)	Arthur Chun-Wing Lau ; Loletta Kit-Ying So	Severe acute respiratory syndrome treatment: present status and future strategy.
000383 (2003)	Guido Antonelli ; Carolina Scagnolari ; Elisa Vicenzi ; Massimo Clementi	Treatment of SARS with human interferons.
000384 (2003)	Hisashi Moriguchi ; Chifumi Sato	Treatment of SARS with human interferons.
000420 (2003)	Ekachai Jenwitheesuk [États-Unis] ; Ram Samudrala	Identifying inhibitors of the SARS coronavirus proteinase.
000438 (2003)	Harri Hemil [Finlande]	Vitamin C and SARS coronavirus
000621 (2004)	Bart L. Haagmans [Pays-Bas] ; Thijs Kuiken ; Byron E. Martina ; Ron A M. Fouchier ; Guus F. Rimmelzwaan ; Geert Van Amerongen ; Debby Van Riel ; Ton De Jong ; Shigeyuki Itamura ; Kwok-Hung Chan ; Masato Tashiro ; Albert D M E. Osterhaus	Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques.
000630 (2004)	Martin Enserink	SARS treatment. Interferon shows promise in monkeys.
000649 (2003)	Pei-Gen Xiao [République populaire de Chine] ; Yong-Yan Wang ; Hong-Shan Chen	[Some research clues on Chinese herbal medicine for SARS prevention and treatment].
000683 (2004)	Lisa E. Hensley [États-Unis] ; Elizabeth A. Fritz [États-Unis] ; Peter B. Jahrling [États-Unis] ; Christopher Karp [États-Unis] ; John W. Huggins [États-Unis] ; Thomas W. Geisbert [États-Unis]	Interferon-β 1a and SARS Coronavirus Replication
000698 (2004)	Ute Ströher [Canada] ; Antonino Dicaro [Italie] ; Yan Li [Canada] ; James E. Strong [Canada] ; Fred Aoki [Canada] ; Frank Plummer [Canada] ; Steven M. Jones [Canada] ; Heinz Feldmann [Canada]	Severe Acute Respiratory Syndrome-Related Coronavirus Is Inhibited by Interferon-α
000714 (2004)	Kenneth Tsang [République populaire de Chine] ; Wing-Hong Seto	Severe acute respiratory syndrome: scientific and anecdotal evidence for drug treatment.
000718 (2004)	Shuwen Liu [États-Unis] ; Gengfu Xiao [République populaire de Chine] ; Yibang Chen [États-Unis] ; Yuxian He [États-Unis] ; Jinkui Niu [États-Unis] ; Carlos R. Escalante [États-Unis] ; Huabao Xiong [États-Unis] ; James Farmar [États-Unis] ; Asim K. Debnath [États-Unis] ; Po Tien [République populaire de Chine] ; Shibo Jiang [États-Unis]	Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors
000739 (2004)	Dale L. Barnard [États-Unis] ; Valerie D. Hubbard ; Jared Burton ; Donald F. Smee ; John D. Morrey ; Michael J. Otto ; Robert W. Sidwell	Inhibition of severe acute respiratory syndrome-associated coronavirus (SARSCoV) by calpain inhibitors and beta-D-N4-hydroxycytidine.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "SARS Virus (drug effects)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "SARS Virus (drug effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    SARS Virus (drug effects)
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021